AAAAAA
Results:
1-14
|
Results: 14
Authors:
LASSITER HA
ROACH JM
GOFF TL
FELDHOFF RC
Citation: Ha. Lassiter et al., HYPOXIC-ISCHEMIC CEREBRAL INJURY IN INFANT RATS - EFFECT OF COMPLEMENT INHIBITION, Molecular immunology, 35(6-7), 1998, pp. 151-151
Authors:
COLE CW
FELDHOFF RC
JUNG E
LASSITER HA
Citation: Cw. Cole et al., ADMINISTRATION OF HUMAN-IMMUNOGLOBULIN-G (IVIG) DEVOID OF ANTI ESCHERICHIA-COLI ANTIBODIES IMPAIRS SURVIVAL OF NEONATAL RATS EXPERIMENTALLYINFECTED WITH ESCHERICHIA-COLI, Pediatrics (Evanston), 102(3), 1998, pp. 752-752
Authors:
JUNG E
FELDHOFF RC
WALZ BM
DREHS MM
BUCHHEIT JQ
LASSITER HA
Citation: E. Jung et al., COMPLEMENT COMPONENT C9 ENHANCES THE CAPACITY OF BETA-LACTAM ANTIBIOTICS TO KILL ESCHERICHIA-COLI IN-VITRO AND IN-VIVO, The American journal of the medical sciences, 315(5), 1998, pp. 307-313
Authors:
LASSITER HA
WALZ BM
WILSON JL
JUNG E
CALISI CR
GOLDSMITH LJ
WILSON RA
MORGAN BP
FELDHOFF RC
Citation: Ha. Lassiter et al., THE ADMINISTRATION OF COMPLEMENT COMPONENT C9 ENHANCES THE SURVIVAL OF NEONATAL RATS WITH ESCHERICHIA-COLI SEPSIS, Pediatric research, 42(1), 1997, pp. 128-136
Authors:
JUNG E
WALZ BM
DREHS MM
FELDHOFF RC
LASSITER HA
Citation: E. Jung et al., COMPLEMENT COMPONENT C9 (C9) POTENTIATES THE PROTECTIVE EFFECT OF CEFOTAXIME IN NEONATAL RATS SEPTIC WITH ESCHERICHIA-COLI, Pediatric research, 39(4), 1996, pp. 1759-1759
Authors:
FELDHOFF RC
WALZ BM
CALISI CR
KIM J
LASSITER HA
Citation: Rc. Feldhoff et al., COMPLEMENT COMPONENT C9 - IMPROVED PURIFICATION METHOD AND UTILIZATION IN STUDIES OF NEONATAL C9 DEFICIENCY, The FASEB journal, 9(6), 1995, pp. 1373-1373
Authors:
LASSITER HA
MCCARTY SC
GOLDSMITH LJ
FELDHOFF RC
Citation: Ha. Lassiter et al., THE RELATIONSHIP OF POSTNATAL AGE TO THE CONCENTRATION OF COMPLEMENT COMPONENT C9 IN THE SERA OF PREMATURE AND FULL-TERM NEONATES, Pediatric research, 37(4), 1995, pp. 294-294
Authors:
LASSITER HA
WALZ BM
MORGAN BP
CALISI CR
FELDHOFF RC
Citation: Ha. Lassiter et al., HUMAN-COMPLEMENT COMPONENT C9 ENHANCES THE SURVIVAL OF NEONATAL RATS SEPTIC WITH ESCHERICHIA-COLI, Pediatric research, 37(4), 1995, pp. 294-294
Authors:
SMITH CL
WEINER DL
LASSITER HA
EZEKOWITZ RAB
Citation: Cl. Smith et al., DECREASED SERUM MANNOSE-BINDING PROTEIN (MBP) LEVELS IN SERA FROM PRETERM NEONATES CORRELATE WITH DELAYED C3 DEPOSITION ON GROUP-B STREPTOCOCCI, Pediatric research, 37(4), 1995, pp. 299-299
Authors:
LASSITER HA
Citation: Ha. Lassiter, THE ROLE OF IMMUNODEFICIENCY IN THE DEVELOPMENT OF POSTOPERATIVE BACTERIAL SEPSIS AND WOUND INFECTIONS IN NEONATES, Pediatric surgery international, 9(7), 1994, pp. 474-478
Authors:
LASSITER HA
WILSON JL
Citation: Ha. Lassiter et Jl. Wilson, IN-VITRO SUPPLEMENTATION WITH HUMAN C9 ENHANCES THE HEMOLYTIC AND BACTERICIDAL ACTIVITY OF NEONATAL RAT SERUM, Pediatric research, 35(4), 1994, pp. 10000299-10000299
Authors:
WILSON JL
FELDHOFF RC
BROWN VE
MORGAN BP
LASSITER HA
Citation: Jl. Wilson et al., COMPLEMENT COMPONENT C9 IN THE NEONATAL RAT, Pediatric research, 35(4), 1994, pp. 10000306-10000306
Authors:
LASSITER HA
WILSON JL
FELDHOFF RC
HOFFPAUIR JM
KLUEBER KM
Citation: Ha. Lassiter et al., SUPPLEMENTAL COMPLEMENT COMPONENT C9 ENHANCES THE CAPACITY OF NEONATAL SERUM TO KILL MULTIPLE ISOLATES OF PATHOGENIC ESCHERICHIA-COLI, Pediatric research, 35(4), 1994, pp. 389-396
Authors:
WILSON JL
FELDHOFF RC
BROWN VE
MORGAN BP
LASSITER HA
Citation: Jl. Wilson et al., COMPLEMENT COMPONENT C9 IN THE NEONATAL RAT, Clinical research, 41(4), 1993, pp. 10000765-10000765
Risultati:
1-14
|